1631.3000 10.10 (0.62%)
NSE Jun 25, 2026 12:25 PM
Volume: 103.7K
 

1631.30
0.62%
Sharekhan
Ipca’s board would discuss the strategic integration of Bayshore Pharmaceuticals’ generics business into Unichem Pharma (USA) Inc on September 30, 2024.
Ipca Laboratories Ltd. has an average target of 1793.75 from 4 brokers.
More from Ipca Laboratories Ltd.
Recommended